Andes, D. R., Safdar, N., Baddley, J. W., Playford, G., Reboli, A. C., Rex, J. H., Sobel, J. D., Pappas, P. G., & Kullberg, B. J. (2012). Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: A patient-level quantitative review of randomized trials. In Clinical Infectious Diseases (Vol. 54, Issue 8, pp. 1110–1122). doi: 10.1093/cid/cis021

Azanza Perea, J. R. (2016). Equinocandinas: aspectos aplicados de la farmacología. Revista Iberoamericana de Micología, 33(3), 140–144. doi: 10.1016/J.RIAM.2016.02.004

Barantsevich, N., & Barantsevich, E. (2022). Diagnosis and Treatment of Invasive Candidiasis. Antibiotics, 11(6). doi: 10.3390/antibiotics11060718

Benjamin, D. K., Stoll, B. J., Gantz, M. G., Walsh, M. C., Sánchez, P. J., Das, A., Shankaran, S., Higgins, R. D., Auten, K. J., Miller, N. A., Walsh, T. J., Laptook, A. R., Carlo, W. A., Kennedy, K. A., Finer, N. N., Duara, S., Schibler, K., Chapman, R. L., Van Meurs, K. P., … Goldberg, R. N. (2010). Neonatal candidiasis: Epidemiology, risk factors, and clinical judgment. Pediatrics, 126(4). doi: 10.1542/peds.2009-3412

Bhattacharya, S., Sae-Tia, S., & Fries, B. C. (2020). Candidiasis and mechanisms of antifungal resistance. In Antibiotics (Vol. 9, Issue 6, pp. 1–19). MDPI AG. doi: 10.3390/antibiotics9060312

Calderone, R. A., & Fonzi, W. A. (2001). Virulence factors of Candida albicans. Trends in Microbiology, 9(7), 327–335. doi: https://doi.org/10.1016/S0966-842X(01)02094-7

Camp, I., Spettel, K., & Willinger, B. (2020). Molecular methods for the diagnosis of invasive candidiasis. In Journal of Fungi (Vol. 6, Issue 3, pp. 1–14). MDPI AG. doi: 10.3390/jof6030101

Chamorro-Petronacci, C., García-García, A., Lorenzo-Pouso, A. I., Gómez-García, F. J., Padín-Iruegas, M. E., Gándara-Vila, P., Blanco-Carrión, A., & Pérez-Sayáns, M. (2019). Management options for low-dose methotrexate-induced oral ulcers: A systematic review. Medicina Oral Patologia Oral y Cirugia Bucal, 24(2), e172–e180. doi: 10.4317/medoral.22978

Clancy, C. J., & Nguyen, M. H. (2013). Finding the “Missing 50%” of Invasive Candidiasis: How Nonculture Diagnostics Will Improve Understanding of Disease Spectrum and Transform Patient Care. Clinical Infectious Diseases, 56(9), 1284–1292. doi: 10.1093/cid/cit006

Coronado-Castellote, L., & Jiménez-Soriano, Y. (2013). Clinical and microbiological diagnosis of oral candidiasis. Journal of Clinical and Experimental Dentistry, 5(5), 279–286. doi: 10.4317/jced.51242

Diaz, P. I., Hong, B. Y., Dupuy, A. K., Choquette, L., Thompson, A., Salner, A. L., Schauer, P. K., Hegde, U., Burleson, J. A., Strausbaugh, L. D., Peterson, D. E., & Dongari-Bagtzoglou, A. (2019). Integrated analysis of clinical and microbiome risk factors associated with the development of oral candidiasis during cancer chemotherapy. Journal of Fungi, 5(2). doi: 10.3390/jof5020049

dos Santos, M. M., & Ishida, K. (2023). We need to talk about Candida tropicalis: Virulence factors and survival mechanisms. Medical Mycology, 61(8), myad075. doi: 10.1093/mmy/myad075

Ellepola, A. N. B., & Morrison, C. J. (2005). Laboratory diagnosis of invasive candidiasis. Journal of Microbiology, 43 Spec No, 65–84. Retrieved from https://api.semanticscholar.org/CorpusID:17849847

Garcia-Rubio, R., de Oliveira, H. C., Rivera, J., & Trevijano-Contador, N. (2020). The Fungal Cell Wall: Candida, Cryptococcus, and Aspergillus Species. Frontiers in Microbiology, 10, 492056. doi: 10.3389/FMICB.2019.02993/BIBTEX

Georgopapadakou, N. H. (1998). Antifungals: mechanism of action and resistance, established and novel drugs. Current Opinion in Microbiology, 1(5), 547–557. doi: https://doi.org/10.1016/S1369-5274(98)80087-8

Gonçalves, B., Azevedo, N., Osório, H., Henriques, M., & Silva, S. (2021). Revealing Candida glabrata biofilm matrix proteome: global characterization and pH response. Biochemical Journal, 478(4), 961–974. doi: 10.1042/BCJ20200844

Gow, N. A. R., Van De Veerdonk, F. L., Brown, A. J. P., & Netea, M. G. (2011). Candida albicans morphogenesis and host defence: discriminating invasion from colonization. Nature Reviews. Microbiology, 10(2), 112. doi: 10.1038/NRMICRO2711

Hassan, Y., Chew, S. Y., & Than, L. T. L. (2021). Candida glabrata: Pathogenicity and resistance mechanisms for adaptation and survival. In Journal of Fungi (Vol. 7, Issue 8). MDPI AG. doi: 10.3390/jof7080667

Johal, H. S., Garg, T., Rath, G., & Goyal, A. K. (2016). Advanced topical drug delivery system for the management of vaginal candidiasis. In Drug Delivery (Vol. 23, Issue 2, pp. 550–563). Taylor and Francis Ltd. doi: 10.3109/10717544.2014.928760

Kondori, N., Nowrouzian, F., Ajdari, M., Hesselmar, B., Saalman, R., Wold, A. E., & Adlerberth, I. (2020). Candida species as commensal gut colonizers: A study of 133 longitudinally followed Swedish infants. Medical Mycology, 58(4), 485–492. doi: 10.1093/mmy/myz091

Lee, Y., Puumala, E., Robbins, N., & Cowen, L. E. (2021). Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and beyond. In Chemical Reviews (Vol. 121, Issue 6, pp. 3390–3411). American Chemical Society. doi: 10.1021/acs.chemrev.0c00199

Letscher-Bru, V., & Herbrecht, R. (2003). Caspofungin: the first representative of a new antifungal class. Journal of Antimicrobial Chemotherapy, 51(3), 513–521. doi: 10.1093/JAC/DKG117

Lim, C. S. Y., Rosli, R., Seow, H. F., & Chong, P. P. (2012). Candida and invasive candidiasis: Back to basics. In European Journal of Clinical Microbiology and Infectious Diseases (Vol. 31, Issue 1, pp. 21–31). doi: 10.1007/s10096-011-1273-3

Marty, M., Bourrat, E., Vaysse, F., Bonner, M., & Bailleul-Forestier, I. (2015). Direct Microscopy: A Useful Tool to Diagnose Oral Candidiasis in Children and Adolescents. In Mycopathologia (Vol. 180, Issues 5–6, pp. 373–377). Springer Netherlands. doi: 10.1007/s11046-015-9933-y

Mishra, A. A., & Koh, A. Y. (2021). The microbial and host factors that govern Candida gastrointestinal colonization and dissemination. Current Opinion in Microbiology, 63, 29–35. doi: https://doi.org/10.1016/j.mib.2021.05.012

Nobile, C. J., & Johnson, A. D. (2015). Candida albicans Biofilms and Human Disease. Annual Review of Microbiology, 69(1), 71–92. doi: 10.1146/ANNUREV-MICRO-091014-104330/CITE/REFWORKS

Nocua-Báez, L. C., Uribe-Jerez, P., Tarazona-Guaranga, L., Robles, R., Cortés, J. A., Nocua-Báez, L. C., Uribe-Jerez, P., Tarazona-Guaranga, L., Robles, R., & Cortés, J. A. (2020). Azoles de antes y ahora: una revisión. Revista Chilena de Infectología, 37(3), 219–230. doi: 10.4067/S0716-10182020000300219

Paul, S., Shaw, D., Joshi, H., Singh, S., Chakrabarti, A., Rudramurthy, S. M., & Ghosh, A. K. (2022). Mechanisms of azole antifungal resistance in clinical isolates of Candida tropicalis. PLOS ONE, 17(7), e0269721. doi: 10.1371/JOURNAL.PONE.0269721

Pereira, L. C., Fernandes Correia, A., Lopes Da Silva, Z. D., Nunes De Resende, C., Brandão, F., Rosane, &, Almeida, M., Yanna, &, & De Medeiros Nóbrega, K. (2021). Vulvovaginal candidiasis and current perspectives: new risk factors and laboratory diagnosis by using MALDI TOF for identifying species in primary infection and recurrence. European Journal of Clinical Microbiology & Infectious Diseases, 1681–1693. doi: 10.1007/s10096-021-04199-1/Published

Pérez, J. C. (2021a). Fungi of the human gut microbiota: Roles and significance. International Journal of Medical Microbiology, 311(3). doi: 10.1016/j.ijmm.2021.151490

Pérez, J. C. (2021b). The interplay between gut bacteria and the yeast Candida albicans. In Gut Microbes (Vol. 13, Issue 1). Taylor and Francis Ltd. doi: 10.1080/19490976.2021.1979877

Pfaller, M. A. (1992). Laboratory aids in the diagnosis of invasive candidiasis. In Mycopathologia (Vol. 120, Issue 9). Kluwer Academic Publishers.

Rex, J. H., Walsh, T. J., Sobel, J. D., Filler, S. G., Pappas, P. G., Dismukes, W. E., & Edwards, J. E. (n.d.). Practice Guidelines for the Treatment of Candidiasis. Retrieved from https://academic.oup.com/cid/article/30/4/662/420263

Robbins, N., & Cowen, L. E. (2021). Antifungal drug resistance: Deciphering the mechanisms governing multidrug resistance in the fungal pathogen Candida glabrata. Current Biology, 31(23), R1520–R1523. doi: 10.1016/j.cub.2021.09.071

Sakamoto, T., Gotoh, K., Hashimoto, K., Tanamachi, C., & Watanabe, H. (2022). Risk Factors and Clinical Characteristics of Patients with Ocular Candidiasis. Journal of Fungi, 8(5). doi: 10.3390/jof8050497

Seidelman, J., Fleece, M. E., Yang, W. Z., Bloom, A., Lydon, E., Arnold, C., Weber, D. J., & Okeke, N. L. (2019). 1688. Invasive Ocular Candidiasis: Who Is Really at Risk? Open Forum Infectious Diseases, 6(Supplement_2), S617–S618. doi: 10.1093/ofid/ofz360.1552

Shah, C. P., McKey, J., Spirn, M. J., & Maguire, J. (2008). Ocular candidiasis: a review. British Journal of Ophthalmology, 92(4), 466. doi: 10.1136/bjo.2007.133405

Shkalim-Zemer, V., Levi, I., Fischer, S., Tamary, H., Yakobovich, J., Avrahami, G., Gilad, G., Elitzur, S., Yaniv, I., Elhasid, R., Manistersky, M., & Shalit, I. (2018). Response of Symptomatic Persistent Chronic Disseminated Candidiasis to Corticosteroid Therapy in Immunosuppressed Pediatric Patients: Case Study and Review of the Literature. The Pediatric Infectious Disease Journal, 37(7). Retrieved from https://journals.lww.com/pidj/fulltext/2018/07000/response_of_symptomatic_persistent_chronic.13.aspx

Sousa, R. A., Oliveira Diniz, L. M., Lapa Marinho, F. E., Rezende, L. G., Carellos, E. M., & Maia de Castro Romanelli, R. (2022). Risk factors for candidemia in neonates: Systematic review and meta-analysis. Journal of Neonatal Nursing, 28(2), 83–92. doi: https://doi.org/10.1016/j.jnn.2021.08.013

Staniszewska, M. (2019). Virulence Factors in Candida species. Current Protein & Peptide Science, 21(3), 313–323. doi: 10.2174/1389203720666190722152415

Talapko, J., Juzbašić, M., Matijević, T., Pustijanac, E., Bekić, S., Kotris, I., & Škrlec, I. (2021). Candida albicans-the virulence factors and clinical manifestations of infection. Journal of Fungi, 7(2), 1–19. doi: 10.3390/jof7020079

Taudorf, E. H., Jemec, G. B. E., Hay, R. J., & Saunte, D. M. L. (2019). Cutaneous candidiasis – an evidence-based review of topical and systemic treatments to inform clinical practice. In Journal of the European Academy of Dermatology and Venereology (Vol. 33, Issue 10, pp. 1863–1873). Blackwell Publishing Ltd. doi: 10.1111/jdv.15782

Tomer, A., Leonard, L., & Mical, P. (2020). PCR Diagnosis of Invasive Candidiasis: Systematic Review and Meta-Analysis. Journal of Clinical Microbiology, 49(2), 665–670. doi: 10.1128/jcm.01602-10

Voice, R. A., Bradley, S. F., Sangeorzan, J. A., & Kauffman, C. A. (1994). Chronic Candidal Meningitis: An Uncommon Manifestation of Candidiasis. Clinical Infectious Diseases, 19(1), 60–66. doi: 10.1093/clinids/19.1.60

Zhai, B., Ola, M., Rolling, T., Tosini, N. L., Joshowitz, S., Littmann, E. R., Amoretti, L. A., Fontana, E., Wright, R. J., Miranda, E., Veelken, C. A., Morjaria, S. M., Peled, J. U., van den Brink, M. R. M., Babady, N. E., Butler, G., Taur, Y., & Hohl, T. M. (2020). High-resolution mycobiota analysis reveals dynamic intestinal translocation preceding invasive candidiasis. Nature Medicine, 26(1), 59–64. doi: 10.1038/s41591-019-0709-7

Zhang, J., Wang, Z., Gai, C., Yang, F., Yun, X., Jiang, B., Zou, Y., Meng, Q., Zhao, Q., & Chai, X. (2024). Design, synthesis, evaluation and optimization of novel azole analogues as potent antifungal agents. Bioorganic & Medicinal Chemistry, 97, 117543. doi: https://doi.org/10.1016/j.bmc.2023.117543